Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Atkore International Group Inc. Announces Second Quarter 2019 Results

Published

on

Reading Time: 13 minutes

  • Diluted earnings per share decreased by $0.18 to $0.61; Adjusted net
    income per diluted share increased by $0.20 to $0.83
  • Net income decreased by $13.0 million, or 30.6%, to $29.6 million;
    Adjusted EBITDA increased by $11.8 million, or 18.0%, to $77.1 million
  • Full-year Adjusted EBITDA guidance increased to $300.0 million –
    $310.0 million
  • Full-year Adjusted net income per diluted share guidance increased to
    $3.25 – $3.40

HARVEY, Ill.–(BUSINESS WIRE)–Atkore International Group Inc. (the “Company” or “Atkore”) (NYSE: ATKR)
announced earnings for its fiscal 2019 second quarter ended March 29,
2019.

“Atkore again produced strong quarterly results with net sales and
Adjusted EBITDA growth of 5% and 18% year over year, respectively,”
commented Bill Waltz, President and Chief Executive Officer of Atkore.
“Our primary focus on serving customers with the right products and
solutions is a catalyst that has enabled us to raise our full year
guidance for a second time this year and deliver upon our commitments to
our shareholders.”

2019 Second Quarter Results

  Three months ended

(in thousands)

March 29, 2019   March 30, 2018   Change   % Change
Net sales
Electrical Raceway $ 353,514 $ 324,787 $ 28,727 8.8 %
Mechanical Products & Solutions 116,190 120,310 (4,120 ) (3.4 )%
Eliminations (395 ) (97 ) (298 ) 307.2 %

Consolidated operations

$ 469,309   $ 445,000   $ 24,309   5.5 %
 
Adjusted EBITDA
Electrical Raceway $ 67,375 $ 56,404 $ 10,971 19.5 %
Mechanical Products & Solutions 17,421 16,722 699 4.2 %
Unallocated (7,702 ) (7,785 ) 83   (1.1 )%
Consolidated operations $ 77,094   $ 65,341   $ 11,753   18.0 %

Net sales increased by $24.3 million, or 5.5%, to $469.3 million for the
three months ended March 29, 2019 compared to $445.0 million for the
three months ended March 30, 2018. Net sales increased by $28.0 million
primarily due to increased average market prices for all product
categories and the pass-through impact of higher average input costs of
steel, copper, and freight. Additionally, net sales increased by $10.8
million due to the acquisition of Vergokan International NV (“Vergokan”)
over the past twelve months, partly offset by a decrease in net sales of
$4.5 million from the sale of the assets of FlexHead Industries, Inc.
and SprinkFLEX, LLC (together “FlexHead”) in the second quarter of
fiscal 2018. The increase in net sales was partially offset by lower
volume of $6.5 million primarily in the metal conduit and fittings
product category sold within the Electrical Raceway segment and in the
mechanical pipe product category sold within the Mechanical Products &
Solutions segment.

Gross profit increased by $7.9 million, or 7.3%, to $117.1 million for
the three months ended March 29, 2019, as compared to $109.2 million for
the prior-year period. Gross margin increased to 24.9% for the three
months ended March 29, 2019, as compared to 24.5% for the prior-year
period. Gross margin increased primarily due to implemented pricing
strategies and favorable product mix.

Net income decreased by $13.0 million, or 30.6%, to $29.6 million for
the three months ended March 29, 2019 compared to $42.6 million for the
prior-year period primarily due to the fiscal 2018 pre-tax gain of 26.7
million on the sale of the assets FlexHead, partially offset by higher
operating income of $11.3 million.

Adjusted EBITDA increased by $11.8 million, or 18.0%, to $77.1 million
for the three months ended March 29, 2019 compared to $65.3 million for
the three months ended March 30, 2018. The increase was primarily due to
higher gross profit.

Diluted earnings per share on a GAAP basis was $0.61 for the three
months ended March 29, 2019, as compared to $0.79 in the prior-year
period primarily due to the prior year gain on the sale of FlexHead.
Adjusted net income per diluted share increased by $0.20 to $0.83 for
the three months ended March 29, 2019, as compared to $0.63 for the
prior-year period primarily due to higher gross profit.

Segment Results

Electrical Raceway

Net sales increased by $28.7 million, or 8.8%, to $353.5 million for the
three months ended March 29, 2019 compared to $324.8 million for the
three months ended March 30, 2018. The increase was primarily due to
increased average market prices for the metal electrical conduit and
fittings product category of $15.1 million. Additionally, sales
increased $10.8 million as a result of the acquisition of Vergokan
during fiscal 2019. Lastly, sales increased $5.9 million due to higher
volume, primarily in the cable wire product category. The increase in
net sales was partially offset by foreign exchange losses of $3.4
million and by lower volume in the metal conduit and fittings product
category.

Adjusted EBITDA for the three months ended March 29, 2019 increased by
$11.0 million, or 19.5%, to $67.4 million from $56.4 million for the
three months ended March 30, 2018. Adjusted EBITDA margins increased to
19.1% for the three months ended March 29, 2019 compared to 17.4% for
the three months ended March 30, 2018. The increase in Adjusted EBITDA
was largely due to pricing strategies and favorable product mix.

Mechanical Products & Solutions (“MP&S”)

Net sales decreased by $4.1 million, or 3.4%, to $116.2 million for the
three months ended March 29, 2019 compared to $120.3 million for the
three months ended March 30, 2018. The decrease was due to lower volume
of $12.4 million primarily in the mechanical pipe product category and a
decrease in net sales of $4.5 million from the sale of the assets of
FlexHead in the second quarter of fiscal 2018. The sales decrease was
partially offset by $12.8 million of higher average selling prices.

Adjusted EBITDA increased $0.7 million, or 4.2%, to $17.4 million for
the three months ended March 29, 2019 compared to $16.7 million for the
three months ended March 30, 2018. Adjusted EBITDA margins increased to
15.0% for the three months ended March 29, 2019 compared to 13.9% for
the three months ended March 30, 2018. Adjusted EBITDA increased
primarily due to pricing strategies and favorable product mix, partially
offset by lower volume in the mechanical pipe product category as well
as from the sale of the assets of FlexHead in the second quarter of
fiscal 2018.

Full-Year 2019 Guidance

The Company is increasing its expectation of fiscal year 2019 Adjusted
EBITDA to be in the range of $300.0 million – $310.0 million and its
expectation of fiscal year 2019 Adjusted net income per diluted share to
be in the range of $3.25 – $3.40.

Reconciliations of the forward-looking full-year 2019 outlook for
Adjusted EBITDA and Adjusted net income per diluted share are not being
provided as the Company does not currently have sufficient data to
accurately estimate the variables and individual adjustments for such
reconciliations.

Conference Call Information

Atkore management will host a conference call today, May 7, 2019, at 8
a.m. Eastern time, to discuss the Company’s financial results. The
conference call may be accessed by dialing (877) 407-0789 (domestic) or
(201) 689-8562 (international). The call will be available for replay
until May 21, 2019. The replay can be accessed by dialing (844)
512-2921, or for international callers, (412) 317-6671. The passcode for
the live call and the replay is 13689898.

The conference call can also be accessed by dialing 877-407-0789
(domestic) or 201-689-8562 (international). A telephonic replay will be
available approximately three hours after the call by dialing
844-512-2921 (domestic) or 412-317-6671 (international). The passcode
for the replay is 13689898. The replay will be available until 11:59
p.m. (ET) on May 21, 2019.

Interested investors and other parties can also listen to a webcast of
the live conference call by logging onto the Investor Relations section
of the Company’s website at http://investors.atkore.com.
The online replay will be available on the same website immediately
following the call.

To learn more about the Company, please visit the company’s website at http://investors.atkore.com.

About Atkore International Group Inc.

Atkore International Group Inc. is a leading manufacturer of Electrical
Raceway products primarily for the non-residential construction and
renovation markets and Mechanical Products & Solutions for the
construction and industrial markets. The Company manufactures a broad
range of end-to-end integrated products and solutions that are critical
to its customers’ businesses and employs approximately 3,500 people at
58 manufacturing and distribution facilities worldwide. The Company is
headquartered in Harvey, Illinois.

Forward-Looking Statements

This press release contains “forward-looking statements” within the
meaning of the Federal Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, but are not limited to, statements
relating to financial outlook. Some of the forward-looking statements
can be identified by the use of forward-looking terms such as
“believes,” “expects,” “may,” “will,” “shall,” “should,” “would,”
“could,” “seeks,” “aims,” “projects,” “is optimistic,” “intends,”
“plans,” “estimates,” “anticipates” or other comparable terms.
Forward-looking statements include, without limitation, all matters that
are not historical facts. Forward-looking statements are subject to
known and unknown risks and uncertainties, many of which may be beyond
our control. We caution you that forward-looking statements are not
guarantees of future performance or outcomes and that actual performance
and outcomes, including, without limitation, our actual results of
operations, financial condition and liquidity, and the development of
the market in which we operate, may differ materially from those made in
or suggested by the forward-looking statements contained in this press
release. In addition, even if our results of operations, financial
condition and cash flows, and the development of the market in which we
operate, are consistent with the forward-looking statements contained in
this press release, those results or developments may not be indicative
of results or developments in subsequent periods.

A number of important factors, including, without limitation, the risks
and uncertainties discussed under the caption “Risk Factors” in our
Annual Report on Form 10-K, filed with the U.S. Securities and Exchange
Commission (“SEC”) on November 28, 2018 could cause actual results and
outcomes to differ materially from those reflected in the
forward-looking statements. Additional factors that could cause actual
results and outcomes to differ from those reflected in forward-looking
statements include, without limitation: declines in, and uncertainty
regarding, the general business and economic conditions in the United
States and international markets in which we operate; weakness or
another downturn in the United States non-residential construction
industry; changes in prices of raw materials; pricing pressure, reduced
profitability, or loss of market share due to intense competition;
availability and cost of third-party freight carriers and energy; high
levels of imports of products similar to those manufactured by us;
changes in federal, state, local and international governmental
regulations and trade policies; adverse weather conditions; failure to
generate sufficient cash flow from operations or to raise sufficient
funds in the capital markets to satisfy existing obligations and support
the development of our business; increased costs relating to future
capital and operating expenditures to maintain compliance with
environmental, health and safety laws; reduced spending by,
deterioration in the financial condition of, or other adverse
developments with respect to, one or more of our top customers;
increases in our working capital needs, which are substantial and
fluctuate based on economic activity and the market prices for our main
raw materials, including as a result of failure to collect, or delays in
the collection of, cash from the sale of manufactured products; work
stoppage or other interruptions of production at our facilities as a
result of disputes under existing collective bargaining agreements with
labor unions or in connection with negotiations of new collective
bargaining agreements, as a result of supplier financial distress, or
for other reasons; challenges attracting and retaining key personnel or
high-quality employees; changes in our financial obligations relating to
pension plans that we maintain in the United States; reduced production
or distribution capacity due to interruptions in the operations of our
facilities or those of our key suppliers; loss of a substantial number
of our third-party agents or distributors or a dramatic deviation from
the amount of sales they generate; security threats, attacks, or other
disruptions to our information systems, or failure to comply with
complex network security, data privacy and other legal obligations or
the failure to protect sensitive information; possible impairment of
goodwill or other long-lived assets as a result of future triggering
events, such as declines in our cash flow projections or customer
demand; safety and labor risks associated with the manufacture and in
the testing of our products; product liability, construction defect and
warranty claims and litigation relating to our various products, as well
as government inquiries and investigations, and consumer, employment,
tort and other legal proceedings; our ability to protect our
intellectual property and other material proprietary rights; risks
inherent in doing business internationally; our inability to introduce
new products effectively or implement our innovation strategies; the
inability of our customers to pay off the credit lines extended to them
by us in a timely manner and the negative impact on customer relations
resulting from our collections efforts with respect to non-paying or
slow-paying customers; our inability to continue importing raw
materials, component parts and/or finished goods; changes as a result of
comprehensive tax reform; the incurrence of liabilities and the issuance
of additional debt or equity in connection with acquisitions, joint
ventures or divestitures; failure to manage acquisitions successfully,
including identifying, evaluating, and valuing acquisition targets and
integrating acquired companies, businesses or assets; the incurrence of
liabilities in connection with violations of the U.S. Foreign Corrupt
Practices Act and similar foreign anti-corruption laws; the incurrence
of additional expenses, increase in complexity of our supply chain and
potential damage to our reputation with customers resulting from
regulations related to “conflict minerals”; disruptions or impediments
to the receipt of sufficient raw materials resulting from various
anti-terrorism security measures; restrictions contained in our debt
agreements; failure to generate cash sufficient to pay the principal of,
interest on, or other amounts due on our debt; and other factors
described from time to time in documents that we file with the SEC. The
Company assumes no obligation to update the information contained
herein, which speaks only as of the date hereof.

Non-GAAP Financial Information

This press release includes certain financial information, not prepared
in accordance with Generally Accepted Accounting Principles in the
United States (“GAAP”). Because not all companies calculate non-GAAP
financial information identically (or at all), the presentations herein
may not be comparable to other similarly titled measures used by other
companies. Further, these measures should not be considered substitutes
for the performance measures derived in accordance with GAAP. See
non-GAAP reconciliations below in this press release for a
reconciliation of these measures to the most directly comparable GAAP
financial measures.

Adjusted EBITDA and Adjusted EBITDA Margin

We use Adjusted EBITDA and Adjusted EBITDA Margin in evaluating the
performance of our business and in the preparation of our annual
operating budgets and as indicators of business performance and
profitability. We believe Adjusted EBITDA and Adjusted EBITDA Margin
allow us to readily view operating trends, perform analytical
comparisons and identify strategies to improve operating performance.

We define Adjusted EBITDA as net income (loss) before: depreciation and
amortization, interest expense, net, loss (gain) on extinguishment of
debt, income tax expense (benefit), restructuring and impairments,
stock-based compensation, certain legal matters, transaction costs, gain
on sale of a business, gain on sale of joint venture and other items,
such as inventory reserves and adjustments and realized or unrealized
gain (loss) on foreign currency transactions. We believe Adjusted
EBITDA, when presented in conjunction with comparable accounting
principles generally accepted in the United States of America (“GAAP”)
measures, is useful for investors because management uses Adjusted
EBITDA in evaluating the performance of our business. We define Adjusted
EBITDA Margin as Adjusted EBITDA as a percentage of Net sales.

We believe Adjusted EBITDA, when presented in conjunction with
comparable accounting principles generally accepted in the United States
of America (“GAAP”) measures, is useful for investors because management
uses Adjusted EBITDA in evaluating the performance of our business.

Adjusted Net Income and Adjusted Net Income per Share

We use Adjusted net income and Adjusted net income per share in
evaluating the performance of our business and profitability. Management
believes that these measures provide useful information to investors by
offering additional ways of viewing the Company’s results that, when
reconciled to the corresponding GAAP measure provide an indication of
performance and profitability excluding the impact of unusual and or
non-cash items. We define Adjusted net income as net income before
consulting fees, loss on extinguishment of debt, stock-based
compensation, intangible asset amortization, gain on sale of joint
venture, certain legal matters and other items. We define Adjusted net
income per share as basic and diluted earnings per share excluding the
per share impact of consulting fees, loss on extinguishment of debt,
stock-based compensation, intangible asset amortization, gain on sale of
joint venture, certain legal matters and other items. Beginning in March
2018, the Company has excluded the impact of intangible asset
amortization from the calculation of Adjusted net income. Adjusted net
income prepared for periods prior to March 2018 have also been adjusted
to reflect this change.

Leverage Ratio – Net debt/Adjusted EBITDA

We define leverage ratio as the ratio of net debt (total debt less cash
and cash equivalents) to Adjusted EBITDA on a trailing twelve-month
(“TTM”) basis. We believe the leverage ratio is useful to investors as
an alternative liquidity measure.

   
ATKORE INTERNATIONAL GROUP INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
Three months ended Six months ended

(in thousands, except per share data)

March 29, 2019   March 30, 2018 March 29, 2019   March 30, 2018
Net sales $ 469,309 $ 445,000 $ 921,337 $ 859,558
Cost of sales 352,221   335,843   693,993   653,534  
Gross profit 117,088 109,157 227,344 206,024
Selling, general and administrative 56,350 60,118 112,729 111,713
Intangible asset amortization 8,196   7,765   16,410   16,452  
Operating income 52,542 41,274 98,205 77,859
Interest expense, net 13,328 9,286 25,488 15,880
Other (income) expense, net (594 ) (25,962 ) (2,194 ) (25,676 )
Income before income taxes 39,808 57,950 74,911 87,655
Income tax expense 10,253   15,392   18,407   17,908  
Net income $ 29,555   $ 42,558   $ 56,504   $ 69,747  
 
Net income per share
Basic $ 0.62 $ 0.83 $ 1.18 $ 1.22
Diluted $ 0.61 $ 0.79 $ 1.15 $ 1.16
   
ATKORE INTERNATIONAL GROUP INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
 

(in thousands, except share and per share
data)

March 29, 2019 September 30, 2018
Assets
Current Assets:
Cash and cash equivalents $ 51,498 $ 126,662
Accounts receivable, less allowance for doubtful accounts of $1,978
and $1,762, respectively
319,769 265,147
Inventories, net 220,787 221,753
Prepaid expenses and other current assets 47,374   33,576  
Total current assets 639,428 647,138
Property, plant and equipment, net 240,188 213,108
Intangible assets, net 287,801 291,916
Goodwill 179,489 170,129
Deferred tax assets 1,076 162
Other long-term assets 1,927   1,607  
Total Assets $ 1,349,909   $ 1,324,060  
Liabilities and Equity
Current Liabilities:
Short-term debt and current maturities of long-term debt $ $ 26,561
Accounts payable 143,742 156,525
Income tax payable 1,110 542
Accrued compensation and employee benefits 24,470 33,350
Customer liabilities 42,723 3,377
Other current liabilities 40,664   52,392  
Total current liabilities 252,709 272,747
Long-term debt 884,095 877,686
Deferred tax liabilities 23,752 16,510
Other long-term tax liabilities 918 1,443
Pension liabilities 15,906 17,075
Other long-term liabilities 14,032   16,540  
Total Liabilities 1,191,412   1,202,001  
Equity:
Common stock, $0.01 par value, 1,000,000,000 shares authorized,
46,216,192 and 47,079,645 shares issued and outstanding, respectively
463 472
Treasury stock, held at cost, 260,900 and 260,900 shares,
respectively
(2,580 ) (2,580 )
Additional paid-in capital 464,082 457,978
Accumulated deficit (282,943 ) (317,373 )
Accumulated other comprehensive loss (20,525 ) (16,438 )
Total Equity 158,497   122,059  
Total Liabilities and Equity $ 1,349,909   $ 1,324,060  
 
ATKORE INTERNATIONAL GROUP INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Six months ended

(in thousands)

March 29, 2019   March 30, 2018
Operating activities:
Net income $ 56,504 $ 69,747
Adjustments to reconcile net income to net cash provided by
operating activities:
Depreciation and amortization 36,301 33,063
Deferred income taxes (1,101 ) (3,667 )
Gain on sale of a business (26,737 )
Stock-based compensation 4,816 6,334
Other adjustments to net income 3,046 4,611
Changes in operating assets and liabilities, net of effects from
acquisitions
Accounts receivable (4,839 ) (23,636 )
Inventories 8,540 (11,691 )
Accounts payable (19,135 ) (1,194 )
Other, net (41,343 ) 6,388  
Net cash provided by operating activities 42,789 53,218
Investing activities:
Capital expenditures (14,712 ) (17,173 )
Divestiture of business 42,000
Acquisition of businesses, net of cash acquired (57,899 ) (3,350 )
Other, net (194 ) 1,469  
Net cash used in (provided by) investing activities (72,805 ) 22,946
Financing activities:
Borrowings under credit facility 17,000 309,000
Repayments under credit facility (17,000 ) (394,000 )
Repayments of short-term debt (20,980 ) (3,550 )
Repayments of long-term debt (1,217 )
Issuance of long-term debt 426,217
Payment for debt financing costs and fees (5,767 )
Issuance of common stock 1,291 5,299
Repurchase of common stock (24,419 ) (381,805 )
Other, net (677 ) (78 )
Net cash used for financing activities (44,785 ) (45,901 )
Effects of foreign exchange rate changes on cash and cash equivalents (363 ) 911  
Decrease in cash and cash equivalents (75,164 ) 31,174
Cash and cash equivalents at beginning of period 126,662   45,718  
Cash and cash equivalents at end of period $ 51,498   $ 76,892  
Supplementary Cash Flow information
Capital expenditures, not yet paid $ 626 $ 534
   
ATKORE INTERNATIONAL GROUP INC.
ADJUSTED EBITDA
 

The following table presents reconciliations of Adjusted EBITDA to
net income for the periods presented:

 
Three months ended Six months ended

(in thousands)

March 29, 2019   March 30, 2018 March 29, 2019   March 30, 2018
Net income $ 29,555 $ 42,558 $ 56,504 $ 69,747
Interest expense, net 13,328 9,286 25,488 15,880
Income tax expense 10,253 15,392 18,407 17,908
Depreciation and amortization 18,280 15,853 36,301 33,063
Restructuring and impairments 1,085 576 2,472 838
Stock-based compensation 1,834 2,770 4,816 6,334
Certain legal matters 2,286 2,286
Transaction costs 123 1,263 287 1,908
Gain on sale of a business (26,737 ) (26,737 )
Other (a) 2,636   2,094   2,842   2,601  
Adjusted EBITDA $ 77,094   $ 65,341   $ 147,117   $ 123,828  
 
 
(a) Represents other items, such as inventory reserves and
adjustments, realized or unrealized gain (loss) on foreign currency
transactions and release of certain indemnified uncertain tax
positions.

Contacts

Contact:
Keith Whisenand
Vice President – Investor
Relations
708-225-2124
[email protected]

Read full story here


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Rubicon Organics Reports Q1 2024 Financial Results

Published

on

Continue Reading

SCHWAZZE

Schwazze Announces First Quarter 2024 Financial Results

Published

on

schwazze-announces-first-quarter-2024-financial-results

Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time

DENVER, May 15, 2024 /PRNewswire/ — Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) (“Schwazze” or the “Company”), today announced financial and operational results for the first quarter ended March 31, 2024.

“We delivered another period of revenue growth in Q1 as we further refined our retail strategy while contending with the prolonged competitive challenges in Colorado and New Mexico,” said Forrest Hoffmaster, Interim CEO of Schwazze. “Throughout the quarter, we continued to sharpen our pricing and promotional efforts while enhancing the in-store experience, widening assortment, improving in-stock position, and advancing our loyalty program to attract and retain new customers. We also strengthened our wholesale business with quarter-over-quarter growth, while surpassing 30% total door penetration across both states.”

“The Colorado market remains highly competitive with more than 680 active recreational licenses, underscoring the importance of delivering an exceptional customer experience and fully integrated retail support program. Although retail pricing has recently stabilized, Colorado sales in Q1 were down 10% year-over-year due to lower volumes. Nonetheless, we significantly outpaced the market as our sales were up 9%, demonstrating the effectiveness of our operating playbook to compete in challenging environments. We expect to continue driving improvements in customer acquisition, retention, and loyalty as we further increase market share in the state.”

“In New Mexico, the proliferation of new licenses continued to outpace state cannabis sales as store count in Q1 increased 31% year-over-year while the market grew only 13%. In addition to pricing and promotional efforts, we’ve focused on driving traffic into our stores by expanding assortment with high quality flower and delivering an elevated customer experience. The New Mexico regulatory body has also increased its license enforcement efforts in recent months, contributing to more than 70 store closures and a 33% sequential decrease in net new store openings in the first quarter. We will continue to support the New Mexico Cannabis Control Division as it develops its regulatory framework.”

“Over the past four years we have rapidly scaled our footprint through 13 acquisitions, building a leading retail presence in both Colorado and New Mexico. We are beginning to see positive momentum from our pricing and promotional strategy and will remain focused on driving operating efficiencies while further optimizing our assets as we consolidate cultivation facilities and eliminate underperforming stores that do not meet our high-margin thresholds. We believe these initiatives, coupled with our operating playbook and strict cost controls, will enable us to return to stronger levels of profitability moving forward.”

First Quarter 2024 Financial Summary

$ in Thousands USD

Q1 2024

Q4 2023

Q1 2023

Total Revenue

$41,601

$43,325

$40,001

Gross Profit

$17,934

$7,034[1]

$21,849

Operating Expenses

$20,643

$23,276

$16,199

Income (Loss) from Operations

$(2,709)

$(16,242)

$5,650

Adjusted EBITDA[2]

$7,341

$10,953

$14,525

Operating Cash Flow

$(3,700)

$3,452

$(880)

Recent Highlights

  • Announced the grand opening of a medical and recreational dispensary in March under the Everest Apothecary banner in Las Cruces, New Mexico, increasing the Company’s retail footprint to 34 stores across the state.
  • Increased wholesale penetration in the first quarter to more than 30% of total doors in Colorado and New Mexico.
  • Lowell Herb Co. pre-roll sales increased more than 3x quarter-over-quarter in Colorado, where it continues to be the #1 pre-roll in the state.
  • Wana gummy sales up more than 2x quarter-over-quarter in New Mexico.

First Quarter 2024 Financial Results

Total revenue in the first quarter of 2024 increased 4% to $41.6 million compared to $40.0 million for the same quarter last year. The increase was primarily due to growth from new stores compared to the prior year period, partially offset by continued pricing pressure and the proliferation of new licenses in New Mexico.

Gross profit for the first quarter of 2024 was $17.9 million or 43.1% of total revenue, compared to $21.8 million or 54.6% of total revenue for the same quarter last year. The decrease in gross margin was primarily driven by the aforementioned pricing pressure in New Mexico, as well as higher medical sales mix in Colorado.

____________________________

1 Q4 2023 Gross Profit includes one-time, non-cash inventory adjustments of approximately $13.1 million comprised of $3.1 million of product consolidation, obsolescence, and shrinkage expenses, $4.3 million of net realizable value adjustments, and $5.8 million of fair value adjustments on acquired inventory in New Mexico in 2023. 
2  Adjusted EBITDA is a non-GAAP measure as defined by the SEC, and represents earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. The Company uses Adjusted EBITDA as it believes it better explains the results of its core business. See “ADJUSTED EBITDA RECONCILIATION (NON-GAAP)” section herein for an explanation and reconciliations of non-GAAP measure used throughout this release.

Operating expenses for the first quarter of 2024 were $20.6 million compared to $16.2 million for the same quarter last year. The year-ago period benefitted from a payroll tax credit of $3.9M. The remaining increase was primarily driven by personnel expenses and four-wall SG&A costs associated with 21 additional stores in Colorado and New Mexico that are still ramping.

Loss from operations for the first quarter of 2024 was $2.7 million compared to income from operations of $5.6 million in the same quarter last year. Net loss was $16.1 million for the first quarter of 2024 compared to net income of $1.7 million for the same quarter last year.

Adjusted EBITDA for the first quarter of 2024 was $7.3 million compared to $14.5 million for the same quarter last year. The decrease in Adjusted EBITDA was primarily driven by lower gross margin and higher operating expenses associated with the 21 additional stores that are still ramping.

As of March 31, 2024, cash and cash equivalents were $13.2 million compared to $19.2 million on December 31, 2023. Total debt as of March 31, 2024, was $159.7 million compared to $156.8 million on December 31, 2023.

Conference Call

The Company will conduct a conference call today, May 15, 2024, at 5:00 p.m. Eastern time to discuss its results for the first quarter ended March 31, 2024.

Schwazze management will host the conference call, followed by a question-and-answer period. Interested parties may submit questions to the Company prior to the call by emailing [email protected].

Date: Wednesday, May 15, 2024
Time: 5:00 p.m. Eastern time
Toll-free dial-in: (888) 664-6383
International dial-in: (416) 764-8650
Conference ID: 84167910
Webcast: SHWZ Q1 2024 Earnings Call

The conference call will also be broadcast live and available for replay on the investor relations section of the Company’s website at https://ir.schwazze.com.

Toll-free replay number: (888) 390-0541
International replay number: (416) 764-8677
Replay ID: 167910

If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.

About Schwazze

Schwazze (OTCQX: SHWZ) (Cboe CA: SHWZ) is building a premier vertically integrated regional cannabis company with assets in Colorado and New Mexico and will continue to explore taking its operating system to other states where it can develop a differentiated regional leadership position. Schwazze is the parent company of a portfolio of leading cannabis businesses and brands spanning seed to sale.

Schwazze is anchored by a high-performance culture that combines customer-centric thinking and data science to test, measure, and drive decisions and outcomes. The Company’s leadership team has deep expertise in retailing, wholesaling, and building consumer brands at Fortune 500 companies as well as in the cannabis sector.

Medicine Man Technologies, Inc. was Schwazze’s former operating trade name. The corporate entity continues to be named Medicine Man Technologies, Inc. Schwazze derives its name from the pruning technique of a cannabis plant to enhance plant structure and promote healthy growth. To learn more about Schwazze, visit https://schwazze.com/.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include financial outlooks; any projections of net sales, earnings, or other financial items; any statements of the strategies, plans and objectives of our management team for future operations; expectations in connection with the Company’s previously announced business plans; any statements regarding future economic conditions or performance; and statements regarding the intent, belief or current expectations of our management team. Such statements may be preceded by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intends,” “plans,” “strategy,” “prospects,” “anticipate,” “believe,” “approximately,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other words of similar meaning in connection with a discussion of future events or future operating or financial performance, although the absence of these words does not necessarily mean that a statement is not forward-looking. We have based our forward-looking statements on management’s current expectations and assumptions about future events and trends affecting our business and industry. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Therefore, forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control and cannot be predicted or quantified. Consequently, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) regulatory limitations on our products and services and the uncertainty in the application of federal, state, and local laws to our business, and any changes in such laws; (ii) our ability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (iii) our ability to identify, consummate, and integrate anticipated acquisitions; (iv) general industry and economic conditions; (v) our ability to access adequate capital upon terms and conditions that are acceptable to us; (vi) our ability to pay interest and principal on outstanding debt when due; (vii) volatility in credit and market conditions; (viii) the loss of one or more key executives or other key employees; and (ix) other risks and uncertainties related to the cannabis market and our business strategy. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC’s website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise except as required by law.

Investor Relations Contact
Sean Mansouri, CFA or Aaron D’Souza
Elevate IR
(720) 330-2829
[email protected]

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
For the Periods Ended March 31, 2024 and December 31, 2023
Expressed in U.S. Dollars

 March 31,

December 31, 

2024

2023

 

ASSETS

 

Current Assets

Cash & Cash Equivalents

$

13,151,317

$

19,248,932

Accounts Receivable, net of Allowance for Doubtful Accounts

3,356,032

4,261,159

Inventory

26,382,184

25,787,793

Marketable Securities, net of Unrealized Loss of $347,516 and Loss of $1,816, respectively

108,583

456,099

Prepaid Expenses & Other Current Assets

3,502,310

3,914,064

Total Current Assets

46,500,426

53,668,047

Non-Current Assets

Fixed Assets, net Accumulated Depreciation of $10,061,700 and $8,741,782, respectively

31,326,000

31,113,630

Investments

2,000,000

2,000,000

Investments Held for Sale

202,111

Goodwill

67,492,705

67,499,199

Intangible Assets, net Accumulated Amortization of $36,483,160 and $32,706,765, respectively

162,391,482

166,167,877

Other Non-Current Assets

1,328,187

1,263,837

Operating Lease Right of Use Assets

34,575,832

34,233,142

Deferred Tax Assets, net

992,144

1,996,489

Total Non-Current Assets

300,106,350

304,476,285

Total Assets

$

346,606,776

$

358,144,332

 

LIABILITIES & STOCKHOLDERS’ EQUITY

 

Current Liabilities

Accounts Payable

$

9,443,233

$

13,341,561

Accrued Expenses

8,106,618

7,774,691

Derivative Liabilities

1,319,845

638,020

Lease Liabilities – Current

5,186,316

4,922,724

Current Portion of Long Term Debt

29,579,713

3,547,011

Income Taxes Payable

28,235,039

25,232,782

Total Current Liabilities

81,870,764

55,456,789

Non-Current Liabilities

Long Term Debt, net of Debt Discount & Issuance Costs

130,120,753

153,262,203

Lease Liabilities – Non-Current

30,735,072

30,133,452

Total Non-Current Liabilities

160,855,825

183,395,655

Total Liabilities

$

242,726,589

$

238,852,444

Stockholders’ Equity

Preferred Stock, $0.001 Par Value. 10,000,000 Shares Authorized; 82,185 Shares Issued and

82,185 Outstanding as of March 31, 2024 and 85,534 Shares Issued and 85,534 Outstanding as of

December 31, 2023.

82

86

Common Stock, $0.001 Par Value. 250,000,000 Shares Authorized; 79,168,539 Shares Issued

and 78,248,389 Shares Outstanding as of March 31, 2024 and 74,888,392 Shares Issued

and 73,968,242 Shares Outstanding as of December 31, 2023.

79,169

74,888

Additional Paid-In Capital

202,677,665

202,040,968

Accumulated Deficit

(96,843,602)

(80,790,927)

Common Stock Held in Treasury, at Cost, 920,150 Shares Held as of March 31, 2024 and

920,150 Shares Held as of December 31, 2023.

(2,033,127)

(2,033,127)

Total Stockholders’ Equity

103,880,187

119,291,888

Total Liabilities & Stockholders’ Equity

$

346,606,776

$

358,144,332

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME AND (LOSS)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Operating Revenues

Retail

$

37,633,252

$

35,820,111

Wholesale

3,898,320

4,058,925

Other

69,421

121,900

Total Revenue

41,600,993

40,000,936

Total Cost of Goods & Services

23,667,319

18,152,163

Gross Profit

17,933,674

21,848,773

Operating Expenses

Selling, General and Administrative Expenses

11,835,818

10,100,934

Professional Services

1,671,881

1,187,364

Salaries

6,880,988

4,695,971

Stock Based Compensation

253,916

214,544

Total Operating Expenses

20,642,603

16,198,813

Income from Operations

(2,708,929)

5,649,960

Other Income (Expense)

Interest Expense, net

(8,307,369)

(7,745,854)

Unrealized Gain (Loss) on Derivative Liabilities

(681,825)

8,501,685

Other Loss

10,500

Loss on Investment

(33,382)

Unrealized Gain on Investment

(347,516)

1,816

Total Other Income (Expense)

(9,359,592)

757,647

Pre-Tax Net Income (Loss)

(12,068,521)

6,407,607

Provision for Income Taxes

3,984,154

4,662,178

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Less: Accumulated Preferred Stock Dividends for the Period

(2,155,259)

(2,029,394)

Net Income (Loss) Attributable to Common Stockholders

$

(18,207,934)

$

(283,965)

Earnings (Loss) per Share Attributable to Common Stockholders

Basic Earnings (Loss) per Share

$

(0.24)

$

(0.01)

Diluted Earnings (Loss) per Share

$

(0.24)

$

(0.06)

Weighted Average Number of Shares Outstanding – Basic

76,006,932

55,835,501

Weighted Average Number of Shares Outstanding – Diluted

76,006,932

101,608,278

Comprehensive Income (Loss)

$

(16,052,675)

$

1,745,429

MEDICINE MAN TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

(Unaudited)

(Unaudited)

Cash Flows from Operating Activities:

Net Income (Loss) for the Period

$

(16,052,675)

$

1,745,429

Adjustments to Reconcile Net Income (Loss) to Cash for Operating Activities

Depreciation & Amortization

5,096,314

6,151,395

Non-Cash Interest Expense

1,031,431

991,184

Non-Cash Lease Expense

2,871,226

2,251,459

Deferred Taxes

1,004,345

(637,225)

Loss on Investment

202,111

Change in Derivative Liabilities

681,825

(8,501,685)

Amortization of Debt Issuance Costs

421,512

421,513

Amortization of Debt Discount

2,303,246

1,999,933

(Gain) Loss on Investments, net

347,516

(1,816)

Stock Based Compensation

640,974

214,544

Changes in Operating Assets & Liabilities (net of Acquired Amounts):

Accounts Receivable

905,127

(118,181)

Inventory

(587,900)

(3,023,251)

Prepaid Expenses & Other Current Assets

411,754

(3,036,801)

Other Assets

(64,350)

360,674

Change in Operating Lease Liabilities

(2,348,703)

(1,531,765)

Accounts Payable & Other Liabilities

(3,566,401)

(3,464,671)

Income Taxes Payable

3,002,257

5,299,403

Net Cash Provided by (Used in) Operating Activities

(3,700,390)

(879,861)

Cash Flows from Investing Activities:

Collection of Notes Receivable

10,631

Purchase of Fixed Assets

(1,532,287)

(2,913,394)

Net Cash Provided by (Used in) Investing Activities

(1,532,287)

(2,902,763)

Cash Flows from Financing Activities:

Payment on Notes Payable

(864,938)

Net Cash Provided by (Used in) Financing Activities

(864,938)

Net (Decrease) in Cash & Cash Equivalents

(6,097,615)

(3,782,624)

Cash & Cash Equivalents at Beginning of Period

19,248,932

38,949,253

Cash & Cash Equivalents at End of Period

$

13,151,317

$

35,166,628

Supplemental Disclosure of Cash Flow Information:

Cash Paid for Interest

$

4,515,205

$

6,540,748

MEDICINE MAN TECHNOLOGIES, INC.
ADJUSTED EBITDA RECONCILIATION (NON-GAAP)
For the Periods Ended March 31, 2024 and 2023
Expressed in U.S. Dollars

For the Three Months Ended

March 31,

2024

2023

Net Income (Loss)

$

(16,052,675)

$

1,745,429

Interest Expense, net

8,307,369

7,745,854

Provision for Income Taxes

3,984,154

4,662,178

Other (Income) Expense, net of Interest Expense

1,052,223

(8,503,501)

Depreciation & Amortization

5,618,834

6,612,814

Earnings Before Interest, Taxes, Depreciation and

Amortization (EBITDA) (non-GAAP)

$

2,909,905

$

12,262,774

Non-Cash Stock Compensation

253,916

214,544

Deal Related Expenses

637,761

1,195,802

Capital Raise Related Expenses

20,760

35,068

Severance

484,561

118,436

Retention Program Expenses

807,500

280,632

Pre-Operating & Dark Carry Expenses

1,053,837

391,917

One-Time Legal Settlements

417,653

Other Non-Recurring Items

754,751

25,707

Adjusted EBITDA (non-GAAP)

$

7,340,644

$

14,524,880

Revenue

41,600,993

40,000,936

Adjusted EBITDA Percent

17.6 %

36.3 %

View original content:https://www.prnewswire.co.uk/news-releases/schwazze-announces-first-quarter-2024-financial-results-302146858.html

Continue Reading

Cannabis

Polyethylene Films Packaging Market Size to Worth USD 139.98 Bn by 2032

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania